Nitric oxide synthase inhibitors l-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity

[1]  M. Plotkine,et al.  Dose‐ and time‐dependence of l‐NAME neuroprotection in transient focal cerebral ischaemia in rats , 1997, British journal of pharmacology.

[2]  D. Clifford,et al.  Nitric oxide inhibitors attenuate ischemic degeneration in the CA1 region of rat hippocampal slices , 1996, Neuroscience Letters.

[3]  P. Mecocci,et al.  Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  F. Faraci,et al.  7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate. , 1995, Stroke.

[5]  Y. Kumon,et al.  Intraventricular administration of nitric oxide synthase inhibitors prevents delayed neuronal death in gerbil hippocampal CA 1 neurons , 1995, Neuroscience Letters.

[6]  C. Marsden,et al.  Effect of 7‐nitro indazole on quinolinic acid‐induced striatal toxicity in the rat , 1995, Neuroreport.

[7]  J. Seylaz,et al.  Effect of inhibiting NO synthesis on hippocampal extracellular glutamate concentration in seizures induced by kainic acid , 1995, Brain Research.

[8]  G. Nisticó,et al.  Lack of involvement of nitric oxide in the mechanisms of seizures and hippocampal damage produced by kainate and ouabain in rats. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[9]  T. Kadar,et al.  Dose-dependent effect of nitric oxide synthase inhibition following transient forebrain ischemia in gerbils , 1994, Brain Research.

[10]  R. Busse,et al.  Nitric oxide promotes seizure activity in kainate-treated rats. , 1994, Neuroreport.

[11]  M. Moskowitz,et al.  Dual role of nitric oxide in focal cerebral ischemia , 1994, Neuropharmacology.

[12]  R. Beninger,et al.  Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole , 1994, Neuropharmacology.

[13]  M. Kuhar,et al.  Nitric oxide inhibits 3H‐glutamate transport in synaptosomes , 1994, Synapse.

[14]  D. Graham,et al.  Anti‐ischaemic efficacy of a nitric oxide synthase inhibitor and a N‐methyl‐d‐aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia , 1994, British journal of pharmacology.

[15]  C. Wasterlain,et al.  Nitric oxide mediates the sustained opening of NMDA receptor-gated ionic channels which follows transient excitotoxic exposure in hippocampal slices , 1994, Brain Research.

[16]  A. Buchan,et al.  Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase , 1994, Neuroscience.

[17]  S. Nag,et al.  Neurotoxicity in conscious rats following intraventricular SNAP, a nitric oxide donor , 1994, Neuropharmacology.

[18]  M. Errasfa,et al.  Inhibition of protein tyrosine phosphatase activity in HER14 cells by melittin and Ca2+ ionophore A23187. , 1993, European journal of pharmacology.

[19]  J. Drapier,et al.  Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. , 1993, The EMBO journal.

[20]  A. Buisson,et al.  Nitric oxide: an endogenous anticonvulsant substance , 1993, Neuroreport.

[21]  A. Lawrence,et al.  Nitric oxide increases interstitial excitatory amino acid release in the rat dorsomedial medulla oblongata , 1993, Neuroscience Letters.

[22]  K. Tipton,et al.  Reduction of striatal N-methyl-D-aspartate toxicity by inhibition of nitric oxide synthase. , 1993, Biochemical pharmacology.

[23]  K. A. Haberny,et al.  Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis , 1992, Neuroscience Letters.

[24]  R. A. Wallis,et al.  Inhibition of nitric oxide synthase protects against hypoxic neuronal injury. , 1992, Neuroreport.

[25]  P. Beart,et al.  Hippocampal lesions induced by microinjection of the nitric oxide donor nitroprusside. , 1992, European journal of pharmacology.

[26]  J. Garthwaite,et al.  NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.